From 2D to 3D Colorectal Cancer Patient-Derived Organoids (PDOs) and In Vivo Models: Copper(II) Complexes as Promising New Antitumor Agents
Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 19088-19106
DOI: 10.1021/acs.jmedchem.6c00941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 31.07.2026. Verfasst von Katarzyna Choroba und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, University of Silesia, Szkolna 9, 40-006Katowice, Poland. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Agents, Organoids, Copper. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funda??o para a Ci?ncia e a Tecnologia.
Abstract (Originalsprache)
Two copper(II) complexes, (1) [CuCl2(tmp-terpy)] and (2) {[CuCl(tmp-terpy)]·PF6}n, (tmp-terpy-4′-(3,4,5-trimethoxy-phenyl)-2,2′:6′,2″-terpyridine) were designed, characterized, and evaluated for cytotoxicity in 2D human cell models (HCT116, HCT116-DoxR, and in normal primary fibroblasts), and 3D colorectal cancer (CRC) spheroids and patient-derived organoids (PDOs). Both complexes demonstrated potent antiproliferative effects, alone and in combination with the FOLFOX (FF), across all 3D models. Importantly, the cytotoxic effects of complex 1 were significantly more pronounced in tumor-derived PDOs than in normal tissue-derived PDOs. Complex 1 induced reactive oxygen species (ROS) production, triggering intrinsic apoptosis and autophagy, consistent with a multimodal anticancer mechanism. It also exerted a cytostatic effect, as shown by delayed cell-cycle progression, and antiangiogenic activity in vivo without systemic toxicity. Notably, cotreatment of complex 1 with FF significantly potentiated cytotoxicity in 3D tumor spheroids and PDOs tumor-derived-PDOs. [CuCl2(tmp-terpy)] alone or in combination with the FF regimen warrants further evaluation in advanced preclinical models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry, University of Silesia, Szkolna 9, 40-006Katowice, Poland.
- Associate Laboratory i4HB - Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, 2819-516Caparica, Portugal.
- UCIBIO, Departamento de Ciências da Vida, NOVA School of Science and Technology, Campus de Caparica, 2829-516Caparica, Portugal.
- Department of Chemical Organic Technology and Petrochemistry, Silesian University of Technology, Krzywoustego 4, 44-100Gliwice, Poland.
- Hospital Beatriz Ângelo, Avenida Carlos Teixeira 3, 2674-514Loures, Portugal.
- Hospital da Luz Learning Health, Luz Saúde, Avenida Lusíada 100, 1500-650Lisboa, Portugal.
ORCID-Profile: Katarzyna Choroba, Rita Sequeira, Barbara Machura, Pedro V Baptista, Alexandra R Fernandes
Förderung
- Funda??o para a Ci?ncia e a Tecnologia
Zitieren
APA
Choroba, K., Cordeiro, S., Sequeira, R., Machura, B., Erfurt, K., Guedes, A., Mascarenhas-Lemos, L., Cravo, M., Baptista, P. V., & Fernandes, A. R. (2026). From 2D to 3D Colorectal Cancer Patient-Derived Organoids (PDOs) and In Vivo Models: Copper(II) Complexes as Promising New Antitumor Agents. Journal of Medicinal Chemistry, 69(15), 19088-19106. https://doi.org/10.1021/acs.jmedchem.6c00941
Vancouver
Choroba K, Cordeiro S, Sequeira R, Machura B, Erfurt K, Guedes A, et al. From 2D to 3D Colorectal Cancer Patient-Derived Organoids (PDOs) and In Vivo Models: Copper(II) Complexes as Promising New Antitumor Agents. Journal of Medicinal Chemistry. 2026;69(15):19088-19106. doi:10.1021/acs.jmedchem.6c00941
BibTeX
@article{Choroba2026,
author = {Choroba, Katarzyna and Cordeiro, Sandra and Sequeira, Rita and Machura, Barbara and Erfurt, Karol and Guedes, Ana and Mascarenhas-Lemos, Luís and Cravo, Marília and Baptista, Pedro V and Fernandes, Alexandra R},
title = {From 2D to 3D Colorectal Cancer Patient-Derived Organoids (PDOs) and In Vivo Models: Copper(II) Complexes as Promising New Antitumor Agents},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {15},
pages = {19088--19106},
doi = {10.1021/acs.jmedchem.6c00941}
}
EUVIMED